MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
AMGN Amgen
- 261.220
- +1.940+0.75%
Close Jan 3 16:00 ET
- 261.250
- +0.030+0.01%
Post 20:01 ET
140.41BMarket Cap33.36P/E (TTM)
262.080High259.795Low2.98MVolume260.000Open259.280Pre Close778.20MTurnover0.56%Turnover Ratio20.91P/E (Static)537.53MShares341.71352wk High18.65P/B140.06BFloat Cap253.30052wk Low8.88Dividend TTM536.16MShs Float341.713Historical High3.40%Div YieldTTM0.88%Amplitude7.887Historical Low261.146Avg Price1Lot Size
About Amgen Company
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Company Profile
SymbolAMGN
Company NameAmgen
Listing DateJun 1, 1983
Issue Price18.00
Founded1980
CEOMr. Robert A. Bradway
MarketNASDAQ
Employees26700
Fiscal Year Ends12-31
AddressOne Amgen Center Drive
CityThousand Oaks
ProvinceCalifornia
CountryUnited States of America
Zip Code91320-1799
Phone1-805-447-1000
Websitehttp://www.amgen.com
Company Executives
- Name
- Position
- Salary
- Robert A. Bradway
- Chairman of the Board, President and Chief Executive Officer
- 22.64M
- Peter H. Griffith
- Executive Vice President and Chief Financial Officer
- 6.02M
- Dr. David M. Reese, M.D.
- Executive Vice President and Chief Technology Officer
- 7.90M
- Dr. James E. Bradner, M.D.
- Executive Vice President, Research and Development and Chief Scientific Officer
- --
- Nancy A. Grygiel
- Senior Vice President and Chief Compliance Officer
- --
- Matthew C. Busch
- Vice President, Finance and Chief Accounting Officer
- --
- Murdo Gordon
- Executive Vice President, Global Commercial Operations
- 8.24M
- Rachna Khosla
- Senior Vice President, Business Development
- --
- Derek Miller
- Senior Vice President, Human Resources
- --
- Jonathan P. Graham
- Executive Vice President, General Counsel and Secretary
- --
- Esteban Santos
- Executive Vice President, Operations
- 7.21M
- Charles M. Holley, Jr
- Independent Director
- 369.92K
- Mary E. Klotman
- Independent Director
- --
- Robert A. Eckert
- Lead Independent Director
- 419.92K
- Dr. Wanda M. Austin
- Independent Director
- 359.92K
- Dr. Robert Sanders Willia M.D.
- Independent Director
- 360.86K
- Ellen J. Kullman
- Independent Director
- 360.29K
- Greg C. Garland
- Independent Director
- 379.92K
- Professor Dr. Tyler E. Jacks, PhD
- Independent Director
- 339.92K
- Michael V. Drake
- Independent Director
- 339.92K
- Dr. S. Omar Ishrak
- Independent Director
- 366.47K
- Dr. Ronald D. Sugar
- Independent Director
- 379.92K
- Amy E. Miles
- Independent Director
- 359.92K
- Dr. Brian J. Druker, M.D.
- Independent Director
- 359.92K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
